SuzanneOparilMD
Cardiology • Birmingham, ALProfessor, Medicine, University of Alabama School of Medicine
Dr. Oparil is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1717 6th Ave S
Birmingham, AL 35233Phone+1 800-822-8816Fax+1 205-934-1302
Summary
- Director, Vascular Biology & Hypertension Program
Education & Training
Massachusetts General HospitalResidency, Internal Medicine, 1969 - 1970
Boston University Medical CenterResidency, Internal Medicine, 1968 - 1969- Massachusetts General HospitalResidency, Internal Medicine, 1967 - 1968
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1965 - 1967
Columbia University Vagelos College of Physicians and SurgeonsClass of 1965
Certifications & Licensure
IL State Medical License 1971 - Present
AL State Medical License 1977 - 2023- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2004-2014
- Women's Health Castle Connolly, 2008
- Men's Health Castle Connolly, 2007
- Join now to see all
Clinical Trials
- The Effects of Moderate vs. Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) Monotherapy Start of enrollment: 2008 Mar 01
- Systolic Blood Pressure Intervention Trial Start of enrollment: 2010 Oct 01
- Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure - an Ancillary Study to SPRINT Start of enrollment: 2013 Jun 01
Publications & Presentations
PubMed
- 1 citationsEfficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination Compared With Placebo for Initial Treatment of Hypertension.Anthony Rodgers, Abdul Salam, Aletta E Schutte, William C Cushman, H Asita de Silva
Journal of the American College of Cardiology. 2024-12-10 - 1 citationsEfficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hype...Anthony Rodgers, Abdul Salam, Aletta E Schutte, William C Cushman, H Asita de Silva
Lancet. 2024-10-19 - Association of Integrase Strand Transfer Inhibitor-Based Antiretroviral Therapy With Blood Pressure and Sustained Hypertension in People With Human Immunodeficiency Vi...Mohammed Siddiqui, Greer A Burkholder, Eric Judd, Zhixin Wang, Lisandro D Colantonio
American Journal of Hypertension. 2024-09-16
Journal Articles
- Concordance Between Blood Pressure in the Systolic Blood Pressure Intervention Trial and in Routine Clinical PracticeSuzanne Oparil, Mark A Parkulo, Priscilla Pemu, Paul K Whelton, JAMA Internal Medicine
- Chlorthalidone and Hydrochlorothiazide for Treatment of Patients with HypertensionFranz H Messerli, George C Roush, Suzanne Oparil, JAMA Internal Medicine
- PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINTUdayan Y Bhatt, Clinton B Wright, Vasilios Papademetriou, Joachim H Ix, Michael G Shlipak, Alfred K Cheung, Mark J Sarnak, Jing Chen, Charles Ginsberg, Glenn M Chertow..., Journal of the American Society of Nephrology
- Join now to see all
Authored Content
- Chlorthalidone and Hydrochlorothiazide for Treatment of Patients with HypertensionJune 2020
Press Mentions
David Sibley, MD Began His Career with a Diagnostic BreakthroughFebruary 21st, 2023- Endothelin Receptor Antagonist Effective in Resistant Hypertension: PRECISIONNovember 9th, 2022
- AHA 2022 – Idorsia and Cincor move forward in hypertensionNovember 8th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
